These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33448228)

  • 1. The incidence of unexpected gynaecological malignancies in hysterectomies carried out for benign indications.
    Yildiz G; Mat E; Yildiz P; Gundogdu EC; Basol G; Kurt D; Kale A
    J Obstet Gynaecol; 2021 Feb; 41(2):298-304. PubMed ID: 33448228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of occult malignancies identified during hysterectomies performed for benign indications.
    Topdagi Yilmaz EP; Cimilli Senocak GN; Topdagi YE; Aynaoglu Yildiz G; Kumtepe Y
    J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101620. PubMed ID: 31449888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of unexpected uterine malignancies in hysterectomies carried out for benign indications.
    Ding Y; Han Y; Zhang S; Shi X
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4339-4345. PubMed ID: 36083311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications.
    Mahnert N; Morgan D; Campbell D; Johnston C; As-Sanie S
    Obstet Gynecol; 2015 Feb; 125(2):397-405. PubMed ID: 25569001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
    Multinu F; Casarin J; Tortorella L; Huang Y; Weaver A; Angioni S; Melis GB; Mariani A; Stewart EA; Laughlin-Tommaso SK
    Am J Obstet Gynecol; 2019 Feb; 220(2):179.e1-179.e10. PubMed ID: 30447212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.
    Parsons LHP; Pedersen R; Richardson DL; Kho KA
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():108-112. PubMed ID: 29518640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications.
    Kho KA; Lin K; Hechanova M; Richardson DL
    Obstet Gynecol; 2016 Mar; 127(3):468-473. PubMed ID: 26855091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
    Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
    Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications of hysterectomy.
    Thompson JD; Birch HW
    Clin Obstet Gynecol; 1981 Dec; 24(4):1245-58. PubMed ID: 7333047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected malignancy at the time of hysterectomy performed for a benign indication: A retrospective review.
    Elliott CG; Murji A; Matelski J; Adekola AB; Chrzanowski J; Shirreff L
    PLoS One; 2022; 17(4):e0266338. PubMed ID: 35363824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors of unanticipated pathology in cases of hysterectomy for benign lesion a cross-section study in Al Shifa Medical Complex.
    AbuSaqer SM; Shammala AIHA; Elejla S; Mahdi H; Laban RA; Hamada HA; Zimmo MW
    Cancer Treat Res Commun; 2023; 35():100697. PubMed ID: 36989579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease.
    Wagner P; Kommoss FKF; Kommoss S; Hartkopf AD; Pasternak I; Oberlechner E; Greif K; Wallwiener M; Neis F; Abele H; Krämer B; Reisenauer C; Staebler A; Wallwiener D; Brucker SY; Taran FA
    Gynecol Oncol; 2019 Apr; 153(1):49-54. PubMed ID: 30635214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
    Wasson M; Magtibay P; Magtibay P; Magrina J
    J Minim Invasive Gynecol; 2017; 24(4):665-669. PubMed ID: 28254678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, causes and surgical methods for hysterectomy in Finland, 1987-1989.
    Luoto R; Kaprio J; Keskimäki I; Pohjanlahti JP; Rutanen EM
    Int J Epidemiol; 1994 Apr; 23(2):348-58. PubMed ID: 8082962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected malignancies after laparoscopic-assisted supracervical hysterectomies (LASH): an analysis of 1,584 LASH cases.
    Theben JU; Schellong AR; Altgassen C; Kelling K; Schneider S; Große-Drieling D
    Arch Gynecol Obstet; 2013 Mar; 287(3):455-62. PubMed ID: 23053310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas.
    Damasco MR; Chan PK; Slonim M; Ang WC; Healey MG
    J Minim Invasive Gynecol; 2017; 24(4):659-664. PubMed ID: 28216458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications.
    Desai VB; Wright JD; Schwartz PE; Jorgensen EM; Fan L; Litkouhi B; Lin H; Gross CP; Xu X
    Obstet Gynecol; 2018 Apr; 131(4):642-651. PubMed ID: 29528920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power morcellation for women undergoing laparoscopic supracervical hysterectomy - safety of procedure and clinical experience from 426 cases.
    Rechberger T; Miotła P; Futyma K; Ziętek A; Filipczak A; Rechberger E; Szumiło J; Adamiak-Godlewska A
    Ginekol Pol; 2016; 87(8):546-51. PubMed ID: 27629127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of incidental genital tract malignancies at the time of myomectomy and hysterectomy for benign conditions.
    Yadav G; Rao M; Goyal SB; Singh P; Kathuria P; Gothwal M
    Obstet Gynecol Sci; 2021 Mar; 64(2):209-215. PubMed ID: 33321560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical thrombosis prophylaxis, bleeding complications and thromboembolism in a national cohort of hysterectomy for benign disease.
    Brummer TH; Heikkinen A; Jalkanen J; Fraser J; Mäkinen J; Tomás E; Seppälä T; Sjöberg J; Härkki P
    Hum Reprod; 2012 Jun; 27(6):1628-36. PubMed ID: 22422792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.